...
首页> 外文期刊>European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology >Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure.
【24h】

Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure.

机译:在高血压引起的左心室肥大和心力衰竭的动物模型中,urocortin 2对心脏功能和心律失常倾向的急性影响。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: To test acute effects of the corticotropin-releasing factor-related peptide urocortin 2 (Ucn2) on left ventricular (LV) function and the propensity for ventricular arrhythmias in the isolated heart of an animal model of hypertension-induced heart failure. METHODS AND RESULTS: Hearts from Dahl salt-sensitive rats with severe LV dysfunction were perfused according to Langendorff. Left ventricular developed pressure and the positive and negative derivatives of LV pressure were analysed before and after perfusion with Ucn2 (n = 15) or normal perfusion solution (control, n = 9). Intracellular calcium cycling parameters were assessed by surface fluorometry. Furthermore, monophasic action potential duration (MAPD) and ventricular fibrillation threshold (VFT) were determined, the latter by a train-of-pulses method at increasing voltage to scan the vulnerable period of repolarization. Urocortin 2 significantly affected intracellular calcium cycling and improved LV contractile function and relaxation. Compared with baseline values, Ucn2 significantly decreased MAPD at 30, 50, and 90% repolarization and significantly increased VFT compared with baseline values. No changes were observed in control experiments. CONCLUSION: Administration of Ucn2 rapidly improves LV function and increases VF threshold in failing, isolated rat hearts with increased propensity for ventricular arrhythmias. These observations suggest a potential use of Ucn2 as a safe and novel agent for the treatment of acute heart failure.
机译:目的:在高血压引起的心力衰竭动物模型中,测试促肾上腺皮质激素释放因子相关肽urocortin 2(Ucn2)对离体心脏的左室(LV)功能和室性心律失常倾向的急性影响。方法和结果:根据Langendorff,对Dahl盐敏感性大鼠的严重LV功能障碍的心脏进行灌注。在用Ucn2(n = 15)或正常灌注溶液(对照组,n = 9)灌注前后,分析左心室发育压力和LV压力的正负导数。通过表面荧光法评估细胞内钙循环参数。此外,确定了单相动作电位持续时间(MAPD)和心室纤颤阈值(VFT),后者通过脉冲序列方法在升高的电压下扫描脆弱的复极化期。 Urocortin 2显着影响细胞内钙循环并改善LV收缩功能和松弛。与基线值相比,与基线值相比,Ucn2在30%,50%和90%的复极时显着降低了MAPD,并显着提高了VFT。在对照实验中未观察到变化。结论:Ucn2的使用可以快速改善左室功能,并增加衰竭的离体大鼠心脏的室颤阈值,增加了室性心律失常的倾向。这些观察结果表明,Ucn2作为安全且新颖的药物可用于治疗急性心力衰竭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号